• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Enforcement Report - Week of October 23, 2024

    FDA

    Accord`s Biologic Imuldosa (Ustekinumab) Receives Suppl Approval in US

    FDA

    Accord BioPharma`s HERCESSI 420mg Receives FDA Approval for HER2 Cancers

    PR NEWSWIRE

    Accord BioPharma’s HERCESSI secures FDA approval

    PHARMACEUTICAL TECHNOLOGY

    FDA Approves Accord`s HERCESSI™, Herceptin® Biosimilar

    PR NEWSWIRE

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.